
ACTH 22-39
CAS No. 37548-29-1
ACTH 22-39( Adrenocorticotropic Hormone (22-39) )
Catalog No. M29945 CAS No. 37548-29-1
ACTH (22-39) is an adrenocorticotropic hormone (ACTH) fragment and it is the 22-39 sequence of ACTH.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 311 | Get Quote |
![]() ![]() |
10MG | 437 | Get Quote |
![]() ![]() |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameACTH 22-39
-
NoteResearch use only, not for human use.
-
Brief DescriptionACTH (22-39) is an adrenocorticotropic hormone (ACTH) fragment and it is the 22-39 sequence of ACTH.
-
DescriptionACTH (22-39) is an adrenocorticotropic hormone (ACTH) fragment and it is the 22-39 sequence of ACTH.(In Vitro):ACTH (22-39) contains two proline residues at positions 3 and 15 from the N-terminus.
-
In VitroACTH (22-39) contains two proline residues at positions 3 and 15 from the N-terminus.
-
In Vivo——
-
SynonymsAdrenocorticotropic Hormone (22-39)
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number37548-29-1
-
Formula Weight1985.06
-
Molecular FormulaC90H125N19O32
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 50 mg/mL (25.19 mM)
-
SMILES——
-
Chemical NameSequence:Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
McMillen CL, et al. Negative Ion In-Source Decay Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry for Sequencing Acidic Peptides. J Am Soc Mass Spectrom. 2016 May;27(5):847-55.
molnova catalog



related products
-
Methyl (E)-sinapate
Methyl (E)-sinapate is isolated from the Polygala sibirica L.var. megalopha Fr.
-
Cixiophiopogon A
Cixiophiopogon A is a natural product from Ophiopogon japonicus.
-
YAP/TAZ inhibitor-1
YAP/TAZ inhibitor-1 is a YAP/TAZ inhibitor (IC50 <0.100 μΜ) for the study of abnormal immune function and cancer.